Kikuko Hotta

Active 1996–2024

31
Papers
23,085
Citations
30
h-index
30
i10-index

Citations

Citations per year for Kikuko Hotta1992: 1 citations1994: 3 citations1997: 8 citations1998: 17 citations1999: 13 citations2000: 22 citations2001: 75 citations2002: 316 citations2003: 633 citations2004: 661 citations2005: 656 citations2006: 604 citations2007: 447 citations2008: 406 citations2009: 300 citations2010: 268 citations2011: 243 citations2012: 203 citations2013: 205 citations2014: 182 citations2015: 145 citations2016: 111 citations2017: 121 citations2018: 95 citations2019: 355 citations2020: 320 citations2021: 291 citations2022: 213 citations2023: 120 citations2024: 170 citations2025: 66 citations2026: 3 citations1993: no citations, so this year is not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,477 citing papers, 25.9% of this breakdownJapan: 509 citing papers, 8.9% of this breakdownChina: 386 citing papers, 6.8% of this breakdownUnited Kingdom: 345 citing papers, 6.1% of this breakdownItaly: 275 citing papers, 4.8% of this breakdownGermany: 239 citing papers, 4.2% of this breakdownCanada: 191 citing papers, 3.4% of this breakdownFrance: 173 citing papers, 3% of this breakdownSouth Korea: 156 citing papers, 2.8% of this breakdownAustralia: 153 citing papers, 2.7% of this breakdownSpain: 149 citing papers, 2.6% of this breakdownNetherlands: 99 citing papers, 1.7% of this breakdown
0%25.9%Other 27.1%

Fields

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology15.1%
  • Neuroscience3.9%
  • Immunology and Microbiology2%
  • Nursing1.4%
  • Agricultural and Biological Sciences0.6%
  • Other1.2%

Topics

  • Adipokines, Inflammation, and Metabolic Diseases18.4%
  • Adipose Tissue and Metabolism10.4%
  • Regulation of Appetite and Obesity5.5%
  • Cardiovascular Disease and Adiposity4.4%
  • Liver Disease Diagnosis and Treatment3.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.2%
  • Other55.6%

Coauthors

All papers

Open in search
  1. Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity

    Authors: , , , , , , , , , , , , , , , , , , - Biochemical and Biophysical Research Communications 1999 cited by 4,857

  2. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2001 cited by 3,442

  3. Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2000 cited by 3,131

  4. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway

    Authors: , , , , , , , , , , , , , , - Circulation 2000 cited by 1,730

  5. PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived Protein

    Authors: , , , , , , , , , , , , , , - Diabetes 2001 cited by 1,659

  6. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan

    Authors: , , , , , , , , , , , , , - Human Genetics 2013 cited by 218

  7. Novel Modulator for Endothelial Adhesion Molecules

    Authors: , , , , , , , , , , , , - Circulation 1999 cited by 2,144

  8. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages

    Authors: , , , , , , , , , , , , , , , - Circulation 2001 cited by 1,279

  9. Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys

    Authors: , , , , , , - Diabetes 2001 cited by 1,073

  10. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

    Authors: , , , , , , , , , - BMC Medical Genetics 2010 cited by 182

  11. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease

    Authors: , , , , , , , , , - Journal of Hepatology 2015 cited by 87

  12. Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yusuke Nakamura - Journal of Human Genetics 2009 cited by 141

  13. Adipocytokine Orosomucoid Integrates Inflammatory and Metabolic Signals to Preserve Energy Homeostasis by Resolving Immoderate Inflammation

    Authors: , , , , , , , , , , , , , - Journal of Biological Chemistry 2010 cited by 127

  14. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yong‐Bing Xiang, Y.-T. Gao, Simin Liu, Yijun Song, Soo Heon Kwak, Hyoung Doo Shin, Kyong Soo Park, Caroline Fall, J. Y. Kim, Pak C. Sham, Karen S.L. Lam, Weiwei Zheng, Xiao‐Ou Shu, Hong‐Wen Deng, Hiroshi Ikegami, Ghattu V. Krishnaveni, Dharambir K. Sanghera, Lee‐Ming Chuang, L. Liu, Renming Hu, Youngjo Kim, Makoto Daimon, Kikuko Hotta, Wei Jia, Jaspal S. Kooner, John C. Chambers, Giriraj R. Chandak, Ronald C.W., Shiro Maeda, Rajkumar Dorajoo, Mitsuhiro Yokota, R. Takayanagi, Norihiro Kato, Xu Lin, Ruth J. F. Loos - Diabetologia 2011 cited by 204

  15. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , - Liver International 2009 cited by 84

  16. Characteristics of non‐obese non‐alcoholic fatty liver disease: Effect of genetic and environmental factors

    Authors: , , , , , , , , , , , , , - Hepatology Research 2016 cited by 78

  17. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell

    Authors: , , , , , , , , , , , , , , , - Circulation 2002 cited by 694

  18. Variations in the FTO gene are associated with severe obesity in the Japanese

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Human Genetics 2008 cited by 246

  19. Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation

    Authors: , , , , , , , , , , , , , , , - Digestive Diseases and Sciences 2009 cited by 85

  20. Genomic structure and mutations in adipose-specific gene, adiponectin

    Authors: , , , , , , , , , , , , , - International Journal of Obesity 2000 cited by 377

  21. Identification of SH2-Bβ as a Substrate of the Tyrosine Kinase JAK2 Involved in Growth Hormone Signaling

    Authors: , , , , - Molecular and Cellular Biology 1997 cited by 172

  22. Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity

    Authors: , , , , , , , , , , , , , - Journal of Biological Chemistry 2001 cited by 116

  23. Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , - Scientific Reports 2018 cited by 77

  24. Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Human Genetics 2011 cited by 76